| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |